Ming Li

7.5k citations

253 papers · 4.5k indexed · 1 hit paper · h-index 35

Impact in

Cancer Research top 1%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies

Papers in ⓘ

Pulmonary and Respiratory Medicine 102
- Lung Cancer Treatments and Mutations 50
- Lung Cancer Diagnosis and Treatment 33
- Ferroptosis and cancer prognosis 23
Molecular Biology 87
- RNA modifications and cancer 27

Co-authors: Cheng Zhan (46 shared papers)Qun Wang (37 shared papers)Mengnan Zhao (26 shared papers)Yiwei Huang (23 shared papers)Tao Lu (18 shared papers)Xiaodong Yang (13 shared papers)Jiacheng Yin (8 shared papers)Jiaqi Liang (23 shared papers)
Journals: Frontiers in Oncology (6 papers)PLoS ONE (5 papers)Cancer Medicine (5 papers)BMC Cancer (4 papers)Journal of Thoracic Oncology (3 papers)
Partner nations: China United States Canada

In The Last Decade

Ming Li

235 papers receiving 4.5k citations

Hit Papers

align trajectories log scale

<p>Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades</p> 2019 · 377 citations

Peers

Countries citing papers authored by Ming Li

Since Specialization

Citations

This map shows the geographic impact of Ming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Li more than expected).

Fields of papers citing papers by Ming Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Li. The network helps show where Ming Li may publish in the future.

Co-authors

The 25 scholars most cited alongside Ming Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ming Li Line = papers co-authored together Ming Li links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 253 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	<p>Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades</p> Cancer Management and Research ·Tao Lu, Xiaodong Yang, Yiwei Huang, Mengnan Zhao, Ming Li, Ke Ma, Jiacheng Yin, Cheng Zhan, Qun Wang Hit paper breakdown →	2019	377
2	Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α Circulation ·Zhiyu Dai, Ming Li, John Wharton, Maggie M. Zhu, You‐Yang Zhao	2016	174
3	Homocysteine induces the expression of C-reactive protein via NMDAr-ROS-MAPK-NF-κB signal pathway in rat vascular smooth muscle cells Atherosclerosis ·Xiaoming Pang, Juntian Liu, Jingjing Zhao, Junjun Mao, Xiaolu Zhang, Liuxin Feng, Chunjie Han, Ming Li, Shuyue Wang, Di Wu	2014	127
4	Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer Journal of Cancer ·Jingdan Qiu, Xinying Xue, Chao Hu, Hu Xu, Deqiang Kou, Rong Li, Ming Li	2015	113
5	A role for CCL2 in both tumor progression and immunosurveillance OncoImmunology ·Ming Li, Deborah A. Knight, Linda A. Snyder, Mark J. Smyth, Trina J. Stewart	2013	104
6	In vitro Modeling of Human Pancreatic Duct Epithelial Cell Transformation Defines Gene Expression Changes Induced by K- ras Oncogenic Activation in Pancreatic Carcinogenesis Cancer Research ·Jiaying Qian, Jiangong Niu, Ming Li, Paul J. Chiao, Ming‐Sound Tsao	2005	94
7	Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer BMC Cancer ·Ming Li, Anqi Li, Shuling Zhou, Yan Xu, Yaoxing Xiao, Rui Bi, Wentao Yang	2018	93
8	Integrated Omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact Nature Communications ·Lei Li, Yuhong Wei, Christine To, Chang‐Qi Zhu, Jiefei Tong, Nhu‐An Pham, Paul Taylor, Vladimir Ignatchenko, Alexandr Ignatchenko, Wen Zhang, Dennis Wang, Naoki Yanagawa, Ming Li, Melania Pintilie, Geoffrey Liu, Lakshmi Muthuswamy, Frances A. Shepherd, Ming‐Sound Tsao, Thomas Kislinger, Michael F. Moran	2014	83
9	Effects of probiotics on chemotherapy in patients with lung cancer Oncology Letters ·Yang Tian, Ming Li, Wei Song, Rui Jiang, Yan Li	2019	73
10	Dissecting the single-cell transcriptome network underlying esophagus non-malignant tissues and esophageal squamous cell carcinoma EBioMedicine ·Zhencong Chen, Mengnan Zhao, Jiaqi Liang, Zhengyang Hu, Yiwei Huang, Ming Li, Yanrui Pang, Tao Lu, Qihai Sui, Cheng Zhan, Miao Lin, Weigang Guo, Qun Wang, Lijie Tan	2021	72
11	LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma International Journal of Biological Sciences ·Zhencong Chen, Zhengyang Hu, Qihai Sui, Yiwei Huang, Mengnan Zhao, Ming Li, Jiaqi Liang, Tao Lu, Cheng Zhan, Zongwu Lin, Fenghao Sun, Qun Wang, Lijie Tan	2021	70
12	Robust ECG Biometrics by Fusing Temporal and Cepstral Information Ming Li, Shrikanth Narayanan	2010	70
13	IL-17A Induces Endothelial Inflammation in Systemic Sclerosis via the ERK Signaling Pathway PLoS ONE ·Xiaojing Xing, Ji Yang, Xiaoqin Yang, Yi Wei, Lubing Zhu, Di Gao, Ming Li	2013	68
14	HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer Journal of Experimental & Clinical Cancer Research ·Yiwei Huang, Zhencong Chen, Tao Lu, Guoshu Bi, Ming Li, Jiaqi Liang, Zhengyang Hu, Yuansheng Zheng, Jiacheng Yin, Junjie Xi, Zongwu Lin, Cheng Zhan, Wei Jiang, Qun Wang, Lijie Tan	2021	67
15	Landscape and dynamics of single tumor and immune cells in early and advanced‐stage lung adenocarcinoma SHILAP Revista de lepidopterología ·Zhencong Chen, Yiwei Huang, Zhengyang Hu, Mengnan Zhao, Ming Li, Guoshu Bi, Yuansheng Zheng, Jiaqi Liang, Tao Lu, Wei Jiang, Songtao Xu, Cheng Zhan, Junjie Xi, Qun Wang, Lijie Tan	2021	65
16	Single-cell analysis reveals immune landscape in kidneys of patients with chronic transplant rejection Theranostics ·Yongguang Liu, Jianmin Hu, Ding Liu, Song Zhou, Jun Liao, Guorong Liao, Siqiang Yang, Zefeng Guo, Yuzhu Li, Shichao Li, Hua Chen, Ying Guo, Ming Li, Lipei Fan, Liuyang Li, Anqi Lin, Ming Zhao	2020	60
17	Pemetrexed plus Platinum as the First-Line Treatment Option for Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials PLoS ONE ·Ming Li, Qian Zhang, P Fu, Ping Li, Aimei Peng, Guoliang Zhang, Xiaolian Song, Min Tan, Xuan Li, Yang Liu, Yueping Wu, Suyun Fan, Changhui Wang	2012	50
18	Formononetin inhibits tumor growth by suppression of EGFR-Akt-Mcl-1 axis in non-small cell lung cancer Journal of Experimental & Clinical Cancer Research ·Xinyou Yu, Feng Gao, Wěi Li, Li Zhou, Wenbin Liu, Ming Li	2020	49
19	SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer Journal of Hematology & Oncology ·Ming Li, Anqi Li, Shuling Zhou, Hong Lv, Wentao Yang	2019	49
20	Baicalin ameliorates lupus autoimmunity by inhibiting differentiation of Tfh cells and inducing expansion of Tfr cells Cell Death and Disease ·Ji Yang, Xue Yang, Jie Yang, Ming Li	2019	48

About Ming Li

Ming Li is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Surgery, having authored 253 papers that have together received 4.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (50 papers), Lung Cancer Diagnosis and Treatment (33 papers), Cancer-related molecular mechanisms research (31 papers), RNA modifications and cancer (27 papers), Ferroptosis and cancer prognosis (23 papers), Cancer Immunotherapy and Biomarkers (18 papers), Lung Cancer Research Studies (18 papers) and Cancer Genomics and Diagnostics (12 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.3k citations), Pulmonary and Respiratory Medicine (1.5k citations), Immunology (577 citations) and Molecular Biology (1.7k citations). Ming Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Cheng Zhan, Qun Wang, Mengnan Zhao, Yiwei Huang, Tao Lu, Xiaodong Yang, Jiacheng Yin, Jiaqi Liang, Zhencong Chen and Zhengyang Hu. Their work appears in journals such as Frontiers in Oncology, PLoS ONE, Cancer Medicine, BMC Cancer and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact